Bio Competitors

BIO Stock  USD 345.87  3.69  1.06%   
Bio-Rad Laboratories competes with Spectral, Edwards Lifesciences, Medigus, Outset MedicalInc, and Monogram Orthopaedics; as well as few others. The company runs under Life Sciences Tools & Services sector within Health Care industry. Analyzing Bio Rad competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Bio Rad to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Bio Rad Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Bio Rad competition on your existing holdings.
  
As of the 29th of March 2024, Return On Capital Employed is likely to drop to 0.03. In addition to that, Return On Assets is likely to grow to -0.05. At this time, Bio Rad's Total Assets are very stable compared to the past year. As of the 29th of March 2024, Non Current Assets Total is likely to grow to about 9.7 B, though Non Currrent Assets Other are likely to grow to (1.4 T).
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Rad's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
344.60346.34348.08
Details
Intrinsic
Valuation
LowRealHigh
311.28415.71417.45
Details
Naive
Forecast
LowNextHigh
348.69350.43352.16
Details
6 Analysts
Consensus
LowTargetHigh
476.48523.60581.20
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bio Rad. Your research has to be compared to or analyzed against Bio Rad's peers to derive any actionable benefits. When done correctly, Bio Rad's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Bio-Rad Laboratories.

Bio Rad Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bio Rad and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Bio and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bio-Rad Laboratories does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
MOTSOM
MOVEMGRM
MOVEOM
VEROMGRM
MOVEMOTS
OMMDGS
  
High negative correlations   
MOVEEW
MOTSEW
MGRMEW
MDGSEW
OMEW
VEROEW

Risk-Adjusted Indicators

There is a big difference between Bio Stock performing well and Bio Rad Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bio Rad's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
MDAI  6.46 (0.21) 0.00  0.05  8.24 
 14.69 
 63.68 
EW  1.35  0.27  0.18  0.51  0.96 
 3.87 
 11.23 
MDGS  2.44 (0.64) 0.00 (0.33) 0.00 
 5.97 
 16.23 
OM  4.32 (1.69) 0.00 (0.32) 0.00 
 7.20 
 19.79 
MGRM  3.84 (0.45) 0.00 (0.11) 0.00 
 7.66 
 37.84 
VERO  5.48 (0.78) 0.00 (0.07) 0.00 
 7.50 
 82.57 
MODD  5.56  0.18  0.05  0.22  5.23 
 13.29 
 47.65 
MOTS  6.00 (0.90) 0.00  0.88  0.00 
 7.81 
 97.41 
MOVE  3.52 (0.72) 0.00 (0.80) 0.00 
 6.78 
 22.36 
DXCM  1.46  0.09  0.05  0.22  1.57 
 4.56 
 12.54 

Cross Equities Net Income Analysis

Compare Bio-Rad Laboratories and related stocks such as Spectral AI, Edwards Lifesciences Corp, and Medigus Ltd ADR Net Income Over Time
Select Fundamental
201020112012201320142015201620172018201920202021202220232024
MDAI(4 M)(4 M)(4 M)(4 M)(4 M)(4 M)(4 M)(4 M)(4 M)(4 M)(4 M)(4 M)(2.9 M)(19 M)(18.1 M)
EW82 M236.7 M293.2 M391.7 M811.1 M494.9 M569.5 M622.1 M722.2 MB823.4 M1.5 B1.5 B1.4 B1.5 B
MDGS(3.3 M)(3.3 M)(3.3 M)(1.5 M)(5.8 M)(9.5 M)(9 M)(2.5 M)(6.6 M)(14.2 M)(6.8 M)M(10.2 M)(9.2 M)(9.6 M)
OM(49.8 M)(49.8 M)(49.8 M)(49.8 M)(49.8 M)(49.8 M)(49.8 M)(49.8 M)(49.8 M)(68.3 M)(120.7 M)(131.9 M)(163 M)(172.8 M)(181.4 M)
MGRM(659 K)(659 K)(659 K)(659 K)(659 K)(659 K)(659 K)(659 K)(712.3 K)(1.8 M)(9.1 M)(11.8 M)(13.7 M)(13.7 M)(13.1 M)
VERO(23 M)(23 M)(23 M)(23 M)(23 M)(23 M)(21.8 M)(17.8 M)(28.7 M)(42.3 M)(82.8 M)(22.1 M)(43.6 M)(36.1 M)(37.9 M)
MODD(30 K)(17.5 K)(20.8 K)(22.8 K)(31 K)(31.1 K)(106.6 K)(106.6 K)(2.5 M)(5.3 M)(7.4 M)(18.6 M)(13.9 M)(12.5 M)(11.9 M)
MOTS(6 M)(6 M)(6 M)(6 M)(6 M)(6 M)(8 M)(13.2 M)(22.3 M)(22.6 M)(19.6 M)(18.9 M)(18.1 M)(12.9 M)(13.5 M)
MOVE545 K7.3 M5.6 M574 K(8.4 M)(8.4 M)(8.4 M)(8.4 M)(8.4 M)(8.4 M)(14 M)(22.6 M)(30.2 M)(31.3 M)(29.7 M)
DXCM(4 M)(44.7 M)(54.5 M)(29.8 M)(22.4 M)(57.6 M)(65.6 M)(50.2 M)(127.1 M)101.1 M493.6 M154.7 M341.2 M541.5 M568.6 M

Bio-Rad Laboratories and related stocks such as Spectral AI, Edwards Lifesciences Corp, and Medigus Ltd ADR Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Bio-Rad Laboratories financial statement analysis. It represents the amount of money remaining after all of Bio Rad Laboratories operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Bio Rad Competitive Analysis

The better you understand Bio Rad competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bio Rad's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bio Rad's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BIOMDAIEWMDGSOMMGRMVEROMODDMOTSMOVE
 1.06 
 345.87 
Bio
 0.47 
 2.13 
Spectral
 0.43 
 95.56 
Edwards
 3.52 
 2.74 
Medigus
 0.91 
 2.22 
Outset
 5.63 
 2.44 
Monogram
 4.17 
 0.69 
Venus
 5.13 
 1.85 
Modular
 4.76 
 0.44 
Motus
 2.50 
 0.41 
Movano
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Z Score
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Bio Rad Competition Performance Charts

Five steps to successful analysis of Bio Rad Competition

Bio Rad's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Bio-Rad Laboratories in relation to its competition. Bio Rad's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Bio Rad in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Bio Rad's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Bio-Rad Laboratories, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Bio Rad position

In addition to having Bio Rad in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Materials ETFs Thematic Idea Now

Materials ETFs
Materials ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Materials ETFs theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Materials ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Bio-Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Check out Bio Rad Correlation with its peers.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Bio Stock analysis

When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stocks Directory
Find actively traded stocks across global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is Bio Rad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.56)
Earnings Share
(21.81)
Revenue Per Share
91.453
Quarterly Revenue Growth
(0.07)
Return On Assets
0.0177
The market value of Bio-Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.